These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 19011365)
1. Chronic administration of olanzapine affects Behavioral Satiety Sequence and feeding behavior in female mice. Coccurello R; D'Amato FR; Moles A Eat Weight Disord; 2008 Sep; 13(3):e55-60. PubMed ID: 19011365 [TBL] [Abstract][Full Text] [Related]
2. Chronic administration of olanzapine induces metabolic and food intake alterations: a mouse model of the atypical antipsychotic-associated adverse effects. Coccurello R; Caprioli A; Ghirardi O; Conti R; Ciani B; Daniele S; Bartolomucci A; Moles A Psychopharmacology (Berl); 2006 Jul; 186(4):561-71. PubMed ID: 16758241 [TBL] [Abstract][Full Text] [Related]
3. Acute effects of olanzapine on behavioural expression including the behavioural satiety sequence in female rats. Cooper GD; Goudie AJ; Halford JC J Psychopharmacol; 2010 Jul; 24(7):1069-78. PubMed ID: 19329550 [TBL] [Abstract][Full Text] [Related]
4. Two models for weight gain and hyperphagia as side effects of atypical antipsychotics in male rats: validation with olanzapine and ziprasidone. Shobo M; Yamada H; Mihara T; Kondo Y; Irie M; Harada K; Ni K; Matsuoka N; Kayama Y Behav Brain Res; 2011 Jan; 216(2):561-8. PubMed ID: 20816897 [TBL] [Abstract][Full Text] [Related]
6. A comparison of the effects of olanzapine and risperidone versus placebo on eating behaviors. Roerig JL; Mitchell JE; de Zwaan M; Crosby RD; Gosnell BA; Steffen KJ; Wonderlich SA J Clin Psychopharmacol; 2005 Oct; 25(5):413-8. PubMed ID: 16160615 [TBL] [Abstract][Full Text] [Related]
7. Metabolic Impairments Precede Changes in Hunger and Food Intake Following Short-Term Administration of Second-Generation Antipsychotics. Teff KL; Rickels K; Alshehabi E; Rickels MR J Clin Psychopharmacol; 2015 Oct; 35(5):579-82. PubMed ID: 26274045 [TBL] [Abstract][Full Text] [Related]
8. Effects of the atypical antipsychotic olanzapine on reproductive function and weight gain in female rats. Fell MJ; Marshall KM; Williams J; Neill JC J Psychopharmacol; 2004 Jun; 18(2):149-55. PubMed ID: 15260902 [TBL] [Abstract][Full Text] [Related]
9. Effects of the increase in neuronal fatty acids availability on food intake and satiety in mice. Coccurello R; Caprioli A; Bellantuono S; D'Amato FR; Conti R; Giannessi F; Borsini F; Moles A Psychopharmacology (Berl); 2010 May; 210(1):85-95. PubMed ID: 20232053 [TBL] [Abstract][Full Text] [Related]
10. Metabolic side effects induced by olanzapine treatment are neutralized by CB1 receptor antagonist compounds co-administration in female rats. Lazzari P; Serra V; Marcello S; Pira M; Mastinu A Eur Neuropsychopharmacol; 2017 Jul; 27(7):667-678. PubMed ID: 28377074 [TBL] [Abstract][Full Text] [Related]
12. A murine model of atypical antipsychotic-induced weight gain and metabolic dysregulation. Coccurello R; Moles A Curr Protoc Neurosci; 2010 Jul; Chapter 9():Unit9.33. PubMed ID: 20578036 [TBL] [Abstract][Full Text] [Related]
13. Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: implications for animal models of antipsychotic-induced weight gain. Cooper GD; Harrold JA; Halford JC; Goudie AJ Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):428-36. PubMed ID: 17933447 [TBL] [Abstract][Full Text] [Related]
14. Atypical antipsychotics and effects on feeding: from mice to men. Benarroch L; Kowalchuk C; Wilson V; Teo C; Guenette M; Chintoh A; Nesarajah Y; Taylor V; Selby P; Fletcher P; Remington GJ; Hahn MK Psychopharmacology (Berl); 2016 Jul; 233(14):2629-53. PubMed ID: 27251130 [TBL] [Abstract][Full Text] [Related]
15. Olanzapine-induced weight gain: chronic infusion using osmotic minipumps does not result in stable plasma levels due to degradation of olanzapine in solution. van der Zwaal EM; Luijendijk MC; Adan RA; la Fleur SE Eur J Pharmacol; 2008 May; 585(1):130-6. PubMed ID: 18378227 [TBL] [Abstract][Full Text] [Related]
16. Olanzapine (LY170053, 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine), but not the novel atypical antipsychotic ST2472 (9-piperazin-1-ylpyrrolo[2,1-b][1,3]benzothiazepine), chronic administration induces weight gain, hyperphagia, and metabolic dysregulation in mice. Coccurello R; Caprioli A; Conti R; Ghirardi O; Borsini F; Carminati P; Moles A J Pharmacol Exp Ther; 2008 Sep; 326(3):905-11. PubMed ID: 18567835 [TBL] [Abstract][Full Text] [Related]
17. Effects of atypical antipsychotic drugs on body weight and food intake in dopamine D2 receptor knockout mice. Yoon S; Noh JS; Choi SY; Baik JH Biochem Biophys Res Commun; 2010 Mar; 393(2):235-41. PubMed ID: 20117094 [TBL] [Abstract][Full Text] [Related]
18. The atypical antipsychotic olanzapine enhances ingestive behaviour in the rat: a preliminary study. Thornton-Jones Z; Neill JC; Reynolds GP J Psychopharmacol; 2002 Mar; 16(1):35-7. PubMed ID: 11949769 [TBL] [Abstract][Full Text] [Related]
19. A comparison of the effects of olanzapine and risperidone versus placebo on ghrelin plasma levels. Roerig JL; Steffen KJ; Mitchell JE; Crosby RD; Gosnell BA J Clin Psychopharmacol; 2008 Feb; 28(1):21-6. PubMed ID: 18204336 [TBL] [Abstract][Full Text] [Related]